The clinical guidelines (S3) for endocrine follow-up after pediatric oncological disease provides recommendations for structured follow-up care of these patients. This article focuses on possible late effects interfering with growth and bone metabolism. The assessment of growth is of special importance after pediatric oncological disease. Several factors, such as hormones, nutritional status and integrity of organ function, especially of the liver, kidneys, heart and lungs have a significant impact on growth. Oncological disease and therapy have potential adverse effects on the skeletal system. Regular follow-up monitoring is recommended for early detection and prevention of pathological fractures, bone deformities especially of the lower extremities and secondary osteoporosis.
|Translated title of the contribution||Growth and bone metabolism after oncological disease in childhood and adolescence|
|Journal||Monatsschrift fur Kinderheilkunde|
|Number of pages||7|
|Publication status||Published - 14.02.2015|
Research Areas and Centers
- Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)